CAD PRS

Biomarker

3 papers3 findings

  • Humans3

Effects

1

Incident CAD risk prediction

no changein humans1

1 study
  1. CAD PRS has no effect on incident CAD risk prediction in humans (change in AUC <= 0.002, P > 0.6).

    “neither Lp(a) nor CAD-PRS improved prediction of incident CAD beyond the SMART score”

    Humansbeyond SMART score in ischemic stroke survivors without baseline CAD

    Lipoprotein(a) and Coronary Artery Disease Polygenic Risk Scores Do Not Improve Secondary Manifestations of Arterial Disease Score Prediction of Coronary Events After Ischemic Stroke

    Journal of the American Heart Association10 Oct 2026

Associations

1

Coronary artery disease

upin humans2

2 studies
  1. CAD PRS raises the risk of coronary artery disease in humans (2.32 (95% CI 2.05-2.63)).

    “Relative to intermediate, high CAD PRS was associated with 2.32 (95% CI 2.05-2.63) risk for CAD.”

    Humansrelative to intermediate genetic riskfemales

    Premature Menopause and Polygenic Risk on Incident Coronary Artery Disease among Postmenopausal Women

    AHA Scientific Sessions 2025 abstract3 Nov 2025

  2. CAD PRS raises the risk of coronary artery disease in humans (comparable or higher CAD risk).

    “The top 8% of the PRS distribution exhibited comparable or higher CAD risk than FH carriers.”

    Humanstop 8% of the PRS distribution vs FH carriers

    Population Screening for Polygenic Risk Identifies and Prevents More Cases of Coronary Artery Disease Than Screening for FH

    AHA Scientific Sessions 2025 abstract3 Nov 2025

More on Coronary artery disease

Latest

Nov 2025: 7Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 110 in 12 months
American Journal of Preventive Cardiology

Risk factors for atherosclerosis diverge across vascular beds

Across 468,266 adults followed for 13 years, genetics drove initial disease onset, whereas clinical and lifestyle factors dominated subsequent polyvascular spread and…Across 468,266 adults followed for 13 years, genetics drove initial disease onset, whereas clinical and lifestyle factors dominated subsequent polyvascular spread and mortality.

Cohort study of 468,266 peoplePopulations